MktsMarkets

BioVie Inc.
NASDAQ: BIVIKey statistics
BIVI News
Stories mentioning BIVI from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 3,177 | 4,269 | 2,936 | 1,227 | 1,345 | 4,705 | 1,990 | 2,054 |
| Sales General & Admin | 2,291 | 2,378 | 1,586 | 2,531 | 2,075 | 2,679 | ||
| Total Operating Expenses | 5,385 | 6,262 | 5,285 | 3,663 | 2,988 | 7,293 | 4,122 | 4,791 |
| Operating Income (Loss) | (5,385) | (6,262) | (5,285) | (3,663) | (2,988) | (7,293) | (4,122) | (4,791) |
| Interest Income | ||||||||
| Interest Expense | 6.00 | 6.00 | 5.00 | 67.00 | 256.00 | 439.00 | ||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (5,270) | (6,069) | (5,088) | (3,489) | (2,788) | (7,113) | (4,152) | (4,942) |
| Earnings Per Share (Basic) | (0.70) | (0.77) | (0.98) | (2.36) | (1.51) | (4.55) | (7.00) | (10.93) |
| Earnings Per Share (Diluted) | (0.70) | (0.77) | (0.98) | (2.36) | (1.51) | (4.55) | (7.00) | (10.93) |
| Weighted Average Shares Outstanding (Basic) | 7,544 | 7,921 | 5,214 | 1,477 | 1,851 | 1,572 | 640.00 | 452.00 |
| Weighted Average Shares Outstanding (Diluted) | 7,544 | 7,921 | 5,214 | 1,477 | 1,851 | 1,572 | 640.00 | 452.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BIVI
BioVie Inc. (NASDAQ: BIVI) is a stock listed on the Nasdaq Stock Market under the ticker symbol BIVI. It last traded at $1.37 (Nov 2, 2026, 4:00 PM ET), down 4.2% on the day. That gives BioVie a market capitalisation of $11.7M.
Over the past 52 weeks BIVI has traded between $0.8200 and $3.79.
For the quarter ended Mar 31, 2026 it reported a net loss of $5.3M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$5.3M |
| Dec 31, 2025 | — | -$6.1M |
| Sep 30, 2025 | — | -$5.1M |
| Jun 30, 2025 | — | -$3.5M |
From BioVie’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…